THOMAS L HARRISON
CIK 1247340 · Chrmn/CEO Divers. Agency Serv. · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$17.51M
Companies
11
Total Filings
54
Lifetime Open-Market Net
-$2.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AGEN | Director | 47,545 | $6.83 | $324.7K | $0 | 8 | 2026-07-07 |
| ACXP | Director | — | $1.47 | — | $0 | 4 | 2026-04-22 |
| AFCG | Director | 24,539 | $2.75 | $67.5K | $95.0K | 6 | 2025-11-24 |
| Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Director | 12,500 | $1.30 | $16.2K | $175.0K | 8 | 2018-06-07 |
| SBH | Director | 0 | $16.84 | $0 | -$187.1K | 5 | 2017-12-11 |
| PLx Pharma Inc. (PLXP) Delisted | Director | — | $0.09 | — | $0 | 1 | 2017-04-20 |
| Fifth Street Asset Management Inc. (FSAM) Delisted | Director | 6,000 | — | — | $102.0K | 4 | 2016-03-18 |
| PLx Pharma Inc. (DPRX) Delisted | Director | 18,604 | — | — | $24.0K | 3 | 2016-01-21 |
| EPOCRATES INC (EPOC) Delisted | Director | — | — | — | $0 | 3 | 2013-03-13 |
| Morgans Hotel Group Co. (MHGC) Delisted | Director | 41,269 | — | — | $0 | 5 | 2012-05-21 |
| OMC | Chrmn/CEO Divers. Agency Serv. | 199,149 | $85.95 | $17.12M | -$3.02M | 6 | 2010-03-31 |
Recent Filings · Page 3 of 6
54 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-11 | SBH | Mixed | — | -$15.8K | EDGAR |
| 2017-12-04 | SBH | Mixed | — | -$15.8K | EDGAR |
| 2017-10-03 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-06 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-09 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-08 | SBH | Grant (A) | — | $0 | EDGAR |
| 2017-04-20 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-04 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-20 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-20 | SBH | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.